Key stats
About CSI PHARMACEUTICA
Home page
Inception date
Dec 4, 2013
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
HuaAn Fund Management Co., Ltd.
ISIN
CNE100001QY9
Tightly track the target index, pursue the minimization of tracking deviation and tracking err.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.29%
Health Technology95.69%
Retail Trade1.62%
Distribution Services0.98%
Bonds, Cash & Other1.71%
Cash1.71%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history